genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Vomiting
Drug Discovery
Synthetic Cannabinoid Signaling Elucidated by a BRET Biosensor
News
Study Maps Neural Pathway That Triggers Vomiting after Eating Contaminated Food
News
Extreme Morning Sickness Genes Identified
News
Don’t Rock the Boat: The Genetics of Motion Sickness Uncovered
News
FDA Approves Takeda-Lundbeck Drug for Major Depressive Disorder
Industry News
Axcan to Buy Pancreatic Enzyme Product Firm Eurand for $583M
Cancer
Eisai Gains U.S. Commercialization Rights to Helsinn’s Combination Antiemetic
Cancer
FDA Not Ready to Approve A.P. Pharma’s Treatment for Chemotherapy-Induced Nausea and Vomiting
Cancer
A.P. Pharma Eliminates Another 11 Positions
News
FDA Halts Marketing of Suppository Products Containing Trimethobenzamide HCl
1
2
Page 1 of 2
Scroll Up